OPASNET (173130) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for OPASNET is dated 2024-03-28; the most recent is 2025-12-23. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2025-12-23 | SELL | 증여 | 장수현 Soohyun Jang | CEO | -80.0K | ₩6,750 | -16.1% | ₩540M ($375K) |
| 2025-12-23 | SELL | 증여 | 김윤정 Yunjeong Kim | - | -80.0K | ₩6,750 | -16.1% | ₩540M ($375K) |
| 2025-12-23 | BUY | 수증 | 장수현 Soohyun Jang | CEO | 80.0K | ₩6,750 | +16.1% | ₩540M ($375K) |
| 2025-12-23 | BUY | 수증 | 김윤정 Yunjeong Kim | - | 80.0K | ₩6,750 | +16.1% | ₩540M ($375K) |
| 2024-03-28 | BUY | PROGRAM | 배재성 Bae Jae-seong | Vice President (Internal Director) | 11.6K | ₩8,280 | -5.3% | ₩96M ($67K) |
| 2024-03-28 | BUY | PROGRAM | 장수현 Soohyun Jang | CEO | 300.0K | ₩8,280 | -5.3% | ₩2.5B ($1.7M) |
| 2024-03-28 | BUY | PROGRAM | 장재환 Jaehwan Jang | President (CEO) | 2.8K | ₩8,280 | -5.3% | ₩23M ($16K) |
| 2024-03-28 | BUY | PROGRAM | 김성호 Seongho Kim | President (CEO) | 10 | ₩8,280 | -5.3% | ₩83K ($58) |
| 2024-03-28 | BUY | PROGRAM | 윤명현 Myeonghyeon Yoon | President (CEO) | 1.0K | ₩8,280 | -5.3% | ₩9M ($6K) |
| 2024-03-28 | BUY | PROGRAM | 제갈응식 Zhuge Eungsik | President (CEO) | 1.5K | ₩8,280 | -5.3% | ₩12M ($9K) |
| 2024-03-28 | BUY | PROGRAM | 김윤정 Yunjeong Kim | - | 87.9K | ₩8,280 | -5.3% | ₩728M ($505K) |
| 2024-03-28 | BUY | PROGRAM | 박건상 Park Geon-sang | Head of Pharmaceutical Compounding Department | 85.0K | ₩8,280 | -5.3% | ₩704M ($489K) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for OPASNET. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.